Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cutler

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
American Journal of Human Genetics|February 9, 2006
A comparison of phasing algorithms for trios and unrelated individualsJonathan Marchini, David Cutler, Nick Patterson, et al.
Medical Care|November 6, 2009
Patient, physician, and payment predictors of statin adherenceDavid C Chan, William H Shrank, David Cutler, et al.
Cancer Chemotherapy and Pharmacology|July 31, 2009
Evaluation of the exposure equivalence of oral versus intravenous temozolomideBlanca D Diez, Paul Statkevich, Yali Zhu, et al.
Nucleic Acids Research|September 17, 2010
Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencingWenyi Wang, Peidong Shen, Sreedevi Thiyagarajan, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2022
A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignanciesPatrick M Boland, Christos Fountzilas, Marwan Fakih, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2022
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignanciesWen Wee Ma, Jenny J Li, Nilofer S Azad, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2002
Sequence variations in the public human genome data reflect a bottlenecked population historyGabor Marth, Greg Schuler, Raymond Yeh, et al.
The Journal of Urology|March 20, 2013
Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancerColin P N Dinney, Mark B Fisher, Neema Navai, et al.
The New England Journal of Medicine|August 3, 2012
A systemic approach to containing health care spendingEzekiel Emanuel, Neera Tanden, Stuart Altman, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
American Journal of Human Genetics|February 9, 2006
A comparison of phasing algorithms for trios and unrelated individualsJonathan Marchini, David Cutler, Nick Patterson, et al.
Medical Care|November 6, 2009
Patient, physician, and payment predictors of statin adherenceDavid C Chan, William H Shrank, David Cutler, et al.
Cancer Chemotherapy and Pharmacology|July 31, 2009
Evaluation of the exposure equivalence of oral versus intravenous temozolomideBlanca D Diez, Paul Statkevich, Yali Zhu, et al.
Nucleic Acids Research|September 17, 2010
Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencingWenyi Wang, Peidong Shen, Sreedevi Thiyagarajan, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2022
A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignanciesPatrick M Boland, Christos Fountzilas, Marwan Fakih, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2022
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignanciesWen Wee Ma, Jenny J Li, Nilofer S Azad, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2002
Sequence variations in the public human genome data reflect a bottlenecked population historyGabor Marth, Greg Schuler, Raymond Yeh, et al.
The Journal of Urology|March 20, 2013
Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancerColin P N Dinney, Mark B Fisher, Neema Navai, et al.
The New England Journal of Medicine|August 3, 2012
A systemic approach to containing health care spendingEzekiel Emanuel, Neera Tanden, Stuart Altman, et al.
Pageof 9